Clinical Trial Update: Non-Invasive MASLD Diagnosis & T2D Remission Biomarkers

View source ↗

Summary

Ongoing clinical trial evaluating non-invasive methods for diagnosing metabolic dysfunction-associated steatotic liver disease (MASLD) and identifying biomarker…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatotic Liver Disease
• Non-alcoholic Fatty Liver Disease
• Obesity
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Royal College of Surgeons in Ireland - Medical University of Bahrain | Conditions: MASLD, T2DM (Type 2 Diabetes Mellitus) | Status: ACTIVE_NOT_RECRUITING